Congenital Adrenal Hyperplasia Clinical Trial
Official title:
Surgical Evaluation Of Using The Inner Surface Of The Prepuce In Feminizing Genitoplasty In Cases Of Verilized Females With Congenital Adrenal Hyperplasia
Background and Rationale: The vaginoplasty remains a challenge for the surgeon. The most
commonly used techniques have been: the Y-V plasty described by fortunoff for low vagina, the
pullthrough operation described by Hendren and Crawford for high vagina, and the
passerini-Glazer technique . None of these procedures is entirely satisfactory; with the
first two, the neovagina has a tendency to become stenotic in most cases. Moreover, in the
third, in addition to the high rate of stenosis, which is encountered in a third of case ,
the high rate of urethro-vaginal fistulas is unacceptable
Objectives :
To describe and evaluate a surgical technique for vaginoplasty that is easy to realize with
fewer complications especially vaginal stenosis.
Study population & Sample size : 24 patients suffering from congenital adrenal hyperplasia
(CAH) presenting to outpatient clinic of diabetis Endocrine And Metabolism Pediatric Unit
(DEMPU) of Cairo University Specialized Pediatric Hospital will be considered.
Study Design : non-controlled prospective clinical trial with all patients included in single
group
Methods: Cystoscopy will be done promptly before proceeding to surgery, Confluence depth more
than 20 mm is considered high anomaly, feminizing genitoplasty will be done as a one-stage
procedure, One month after operation, examination under anesthesia will be done with
calibration of vagina.
Possible Risk (s) to study population : The risk of this study is involving a vulnerable
group of females which exposed to lengthy operation may complicate with bleeding and need for
blood transfusion, infection early after surgery or vaginal stenosis.
Outcome parameter (s):
Vaginal calibration using hegars dilators Urodynamics for females older than 3 years and
complaining from incontinence
• Background and Rationale: Disorders of sex development(DSD) are medical conditions in which
the development of chromosomal, gonadal, or anatomic sex varies from normal and may be
incongruent with each other. Five main groups of DSD patients may be identified, submitted to
the gender assignment process, and may be considered for a surgical genital reconstruction.
(Lee Pa et al, 2006) Congenital adrenal hyperplasia (CAH) refers to a group of autosomal
recessive disorders resulting from deficiency of one of the five enzymes required for
synthesis of cortisol in the adrenal cortex. CAH is the most common cause of genital
ambiguity. (van der Zwan, 2013) About 90-95% of individuals with CAH have a mutation in
CYP21A2 gene, encoding 21-hydroxylase enzyme. The worldwide incidence of classical 21 OHD is
1:15,000 to 1:16,000 live births of which approximately 75% are salt wasters. That leads to a
block of normal production of cortisone and results in overproduction of steroid metabolism
by-products through pituitary feedback. These androgenic steroids lead to a variable degree
of masculinization of normal female fetus.
The goal of therapy in CAH is to both correct the deficiency in cortisol secretion and
suppresses adrenocorticotropic hormone (ACTH) overproduction. Proper treatment with
glucocorticoid reduces stimulation of the androgen pathway, thus preventing further
virilization and allowing normal growth and development. In addition to hormonal therapy,
feminizing reconstructive surgery targets the correction of anatomical disturbance. The
feminizing genitoplasty operation consists of reducing the size of the phallus
(clitoroplasty), creating labia minora and vaginoplasty.
• Sample size: Sample size calculation: n = 2(Za+Z1-β)2σ2/Δ2 n sample size Za = 1.65 ( p<0.05
as acceptable and a study with 80% power; using the below table, we get the following values:
Zα, is 1.65 a error 5% 1% .1% 2 sided 1.96 2.5758 3.2905
1 sided 1.65 2.33 Z1-,β= 0.8416 power 80% 85% 90% 95% value 0.8416 1.0364 1.2816 1.6449 σ
standard deviation =0 .5 Δ effect size 36% =0.36 Effect of using the prepuce in minimizing
vaginal stenosis is 100% - effect of using other techniques 64%
N =2(1.65+0.8416)2 0.52 / 0.362 = 24 patients.
• Study Design: non-controlled prospective clinical trial with all patients included in
single group.
- Ethical committee approval : approved (N-100-2018)
- Study Methods
Population of study & disease condition:
24 patients suffering from congenital adrenal hyperplasia (CAH) presenting with virilized
external genitalia to outpatient clinic of diabetes Endocrine And Metabolism Pediatric Unit
(DEMPU) of Cairo University Specialized Pediatric Hospital will be considered.
Methodology in details :
Patient recruitment females with congenital adrenal hyperplasia presenting with persistent
urogenital sinus and virilized external genitalia to the outpatient clinic of Diabetes
Endocrine And Metabolism Pediatric Unit (DEMPU) of Cairo University Specialized Pediatric
Hospital
Pre-operative management History taking laying stress on age at diagnosis, family history of
similar conditions and consanguinity in addition to any salt losing events.
Reviewing the patients charts for the investigations (basal adrenal precursors, karyotype,
pelvic ultrasound) Complete genital examination to detect the degree of virilization (number
and types of openings, the presence of rugae or pigmentation, phallus size and Prader scale).
Routine pre-operative blood tests will be done .
Perioperative hormonal therapy in the form of hydrocortisone and/or fludrocortisone in
conjunction with pediatric anesthesia and pediatric endocrinology teams including dose
adjustment and electrolytes follow up.
Genitography: Patient is generally anesthetized either in same setting of surgery or
pre-operatively in different setting, The depth of confluence from perineal marker is
measured in ratio to perineal marker dimensions whatever the scale of genitography picture
is, then measurements are taken in millimeters. Other measurements of proximal urethra and
vagina to the confluence are taken.
Operative technique Cystoscopy will be done promptly before proceeding to surgery in the same
setting.
Confluence depth more than 20 mm is considered high anomaly with consequent difficult and
lengthy procedure with high probability of need to use vaginal pullthrough in combination
with the use of inner layer of the prepuce.
feminizing genitoplasty will be done as a one-stage procedure. The patient is placed in the
lithotomy position for the best exposure of the perineum. A Foley catheter French 6 is placed
in the vagina to facilitate identification of structures during dissection, The clitoroplasty
will be attempted in all Cases.
The dissection of the flap from the inner surface of the prepuce with its pedicle will be
done after measuring the distance between the native vagina and perineum. and then
tubularized onto a rectal stent (French 12 or 14).
The proximal edge of the preputial flap will be sutured to upper vagina and its distal edge
to outer edge. The rectal drain will be left in the vagina for 5 days postoperatively, by
this technique the vaginoplasty can be achieved without further mobilization of the vagina
which may affect the continence of the patient if we divide pubourethral ligament, labia this
procedure will be followed by clitoroplasty and labioplasty.
In cases of low urogenital sinus (less than 2 cm), the use of preputial flap alone is often
sufficient.
in case of high confluence additional procedure will be done in the form of laparoscopic
vaginal pull-through
Postoperative management:
Wound will be closed by x-shaped bandage for 24 hours.
Vitamin K, ethamsylate (dicynone) and tranexamic acid (cyklokapron) will be given to help in
hemostasis.
After dressing removal the wound will be left exposed and flushed with sterile -saline every
4-6 hours
Urinary catheter and vaginal stent will be removed on 5th to 7th day post operatively.
Parenteral broad spectrum antibiotics and antianaerobes will be given for one week. Stress
doses of steroids will be continued for 2-3 days after surgery at double usual oral dose
followed by tapering and returning to the original dose
postoperative management: One month after operation, examination under anaesthesia will be
done with calibration of vagina using Hegar dilators and making decision for further need for
repeated vaginal dilatation.
Urodynamics will be applied for patients older than 3 years old to asses the continence in
cases with high confluence.
Primary outcome:
To calibrate the vagina and asses the degree of vaginal stenosis if present and need for
further vaginal dilatation.
Secondary outcome:
To asses other outcomes specially the continence in patients older than 3 years old and the
prescence of urethrovaginal fistula.
Short term complications:
- Infection at vestibule and incision lines
- accidental removal of the catheter
- haematoma
- secondary haemorrage
Intermediate and long term complications:
- urethrovaginal fistula
- recurrent persistant urogenital sinus (UGS)
- Vaginal stenosis
- Urinary incontinence
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03687242 -
Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
|
Phase 2 | |
Active, not recruiting |
NCT04544410 -
A Ph2b to Evaluate Tildacerfont in the Reduction of Glucocorticoid Steroid Doses in Adult CAH
|
Phase 2 | |
Not yet recruiting |
NCT04087148 -
Linear Growth of Children With Congenital Adrenal Hyperplasia
|
||
Completed |
NCT03162159 -
Adult Height Prediction in Congenital Adrenal Hyperplasia
|
||
Recruiting |
NCT05687474 -
Baby Detect : Genomic Newborn Screening
|
||
Enrolling by invitation |
NCT05162950 -
Effects and Importance of Epinephrine/Adrenalin Deficiency in CAH
|
||
Withdrawn |
NCT03532022 -
Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement Therapy
|
Phase 3 | |
Recruiting |
NCT02795871 -
Prenatal Dex Study
|
N/A | |
Completed |
NCT02934399 -
Dynamic Hormone Diagnostics in Endocrine Disease
|
||
Recruiting |
NCT04903587 -
Gonadal Changes In Congenital Adrenal Hyperplasia Patients
|
||
Not yet recruiting |
NCT04536662 -
Comparisons of Different Forms of Glucocorticoid on the Recovery of Reproductive Function in Patients With 21α-hydroxylase Deficiency
|
Phase 4 | |
Recruiting |
NCT04463316 -
GROWing Up With Rare GENEtic Syndromes
|
||
Active, not recruiting |
NCT04490915 -
Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia
|
Phase 3 | |
Completed |
NCT01807364 -
Cardiovascular Risk Profile in Patients With Congenital Adrenal Hyperplasia
|
N/A | |
Completed |
NCT02804178 -
A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia
|
Phase 2 | |
Completed |
NCT03019614 -
An Open Label Study in Healthy Volunteers to Compare Chronocort® to Hydrocortisone
|
Phase 1 | |
Not yet recruiting |
NCT04293133 -
Final Height in Patients With CAH
|
||
Recruiting |
NCT05663320 -
A Study of a Virtual Education-Based Transition Intervention to Improve Transition Readiness in Adolescent and Young Adults With Congenital Adrenal Hyperplasia
|
N/A | |
Active, not recruiting |
NCT04806451 -
Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Patients With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)
|
Phase 3 | |
Completed |
NCT01875640 -
Decision Support for Parents Receiving Information About Child's Rare Disease
|